Ortin Global
ORTINGLOBE · Pharma > Pharmaceuticals & Drugs · MD: S Murali Krishna Murthy · Listing date: Aug. 21, 2015

Stock Price vs Company Growth
1d
3.6%
1w
4.8%
1m
5.6%
3m
35.2%
6m
45.2%
1y
43.6%
5y
7.2%
all
1.8%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowMar11Sep14Mar18Sep21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

11 3.6%
9.57
19.5
Company Overview

Sales
81.9 Cr
Growth: 70.3%
Profit after Tax
0.52 Cr
Growth: -59.5%
Micro Cap
8.94 Cr
P/E: 36.7x
Industry P/E: 30.4x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 81.9
Growth 70.3%
EBITDA 7.9%
P/S 0.1x
Dividend 0.0%
P/E 36.7x
Book Value ₹ 25.4
PEG Ratio 0.5x
ROE 2.4%
P/B N/A
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2
Promoters
Sanka Venkata Ratnamma
2.37 %
Sanka Balaji Venkateswarlu
1.88 %
Sanka Murali Krishna Murthy
1.65 %
Sanka Srinivas Kumar
1.63 %
Sanka Venkata Sujatha
1.5 %
Created with Highcharts 8.2.2
Others
Rajesh Poddar
4.69 %
Korripati Pullaiah
3.06 %
Shabbir Nazmuddin Paratha
1.75 %
Survival Technologies Private Ltd
1.24 %
Bp Equities Private Limited
1.03 %
Created with Highcharts 8.2.2
Increase    Decrease    No change
Company Profile Detailed

Ortin Laboratories established in the year 1986 was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public.
Investors (80)